Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept auto-injector versus prefilled syringe satisfaction study in rheumatoid arthritis
2006-006591-37Phase 3Completed
- Sponsor
- Wyeth
- Start
- Jun 2007
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of etanercept in rheumatoid arthritis (RA) (2 arms), sponsored by Wyeth. Primary endpoints: Patient satisfaction at week 12 using a 10-point scale and Patient satisfaction using a dichotomous Yes/No response. Started Jun 2007; status: completed.
02
Drugs
etanercept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2006-006591-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006591-37.